Our newest portfolio company, Alimetry, has now left stealth mode to announce that they have achieved CE Mark on their diagnostic product, which will be followed by work to achieve FDA regulatory approval. From their press release:
“The new wearable product, called Gastric Alimetry, is positioned to transform the diagnostic pathway for millions of patients worldwide suffering from diseases such as functional dyspepsia, gastroparesis and chronic nausea and vomiting. Gastric symptoms are extremely prevalent and impart a vast burden, affecting around 10% of the global population. The Gastric Alimetry device collects data by non-invasively sensing the activity of the stomach from the body surface. The data is sent to the cloud for analysis, and is used by clinicians to determine the causes of gastric symptoms and direct treatment.”
You can read the rest of the press release here: https://www.scoop.co.nz/stories/SC2104/S00017/alimetry-leaves-stealth-mode-to-announce-ce-mark-on-new-wearable-medical-device-for-gastric-diseases-and-investment.htm
Alimetry has also been in the local media after being named a finalist in three categories of the Hi-Tech Awards. There was an article in the NBR, and you can watch the Seven Sharp clip here: https://www.tvnz.co.nz/shows/seven-sharp/clips/kiwi-scientists-come-up-with-solution-to-end-invasive-techniques-to-diagnose-gastric-problems
And their new website is looking very slick, at www.alimetry.com!